Shoulder Innovations, Inc. earnings releases SI

Annual Quarterly

Shoulder Innovations, Inc. last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $16.2 million (+37.7% year over year) and diluted EPS of -$0.34. It usually reports 36–69 days after a quarter ends. Based on that pattern, the next release is estimated for around Mar 9, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–69 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Nov 5, 2026
36 days after quarter end
Q3 FY2026
ended Sep 30, 2026
16
+37.7%
-7
+19.3%
-0.34
+46.9%
Aug 6, 2026
37 days after quarter end
Q2 FY2026
ended Jun 30, 2026
17
+56.0%
-10
+47.1%
-0.49
+99.7%
May 13, 2026
43 days after quarter end
Q1 FY2026
ended Mar 31, 2026
17
-8
-0.41
Mar 10, 2026
69 days after quarter end
Q4 FY2025
ended Dec 31, 2025
14
-8
-0.38
Nov 12, 2025
43 days after quarter end
Q3 FY2025
ended Sep 30, 2025
12
-9
-0.64
Sep 9, 2025
71 days after quarter end
Q2 FY2025
ended Jun 30, 2025
11
-19
-165.53

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SI (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Grand Rapids, MI
SEC filer status
, Emerging growth company
SEC CIK
1699350

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.